188 related articles for article (PubMed ID: 25331549)
1. Efficient and stereocontrolled synthesis of 1,2,4-trioxolanes useful for ferrous iron-dependent drug delivery.
Fontaine SD; DiPasquale AG; Renslo AR
Org Lett; 2014 Nov; 16(21):5776-9. PubMed ID: 25331549
[TBL] [Abstract][Full Text] [Related]
2. Trioxaferroquines as new hybrid antimalarial drugs.
Bellot F; Coslédan F; Vendier L; Brocard J; Meunier B; Robert A
J Med Chem; 2010 May; 53(10):4103-9. PubMed ID: 20443628
[TBL] [Abstract][Full Text] [Related]
3. [Recent advances in the study of artemisinin-related 1,2,4-trioxanes and ozonides (1,2,4-trioxolanes) as antimalarials].
Yang ZS; Li Y
Yao Xue Xue Bao; 2005 Dec; 40(12):1057-63. PubMed ID: 16496665
[No Abstract] [Full Text] [Related]
4. Dispiro-1,2,4-trioxane analogues of a prototype dispiro-1,2,4-trioxolane: mechanistic comparators for artemisinin in the context of reaction pathways with iron(II).
Tang Y; Dong Y; Wang X; Sriraghavan K; Wood JK; Vennerstrom JL
J Org Chem; 2005 Jun; 70(13):5103-10. PubMed ID: 15960511
[TBL] [Abstract][Full Text] [Related]
5. Endoperoxide antimalarials: development, structural diversity and pharmacodynamic aspects with reference to 1,2,4-trioxane-based structural scaffold.
Rudrapal M; Chetia D
Drug Des Devel Ther; 2016; 10():3575-3590. PubMed ID: 27843298
[TBL] [Abstract][Full Text] [Related]
6. Enantiomeric 1,2,4-trioxanes display equivalent in vitro antimalarial activity versus Plasmodium falciparum malaria parasites: implications for the molecular mechanism of action of the artemisinins.
O'Neill PM; Rawe SL; Borstnik K; Miller A; Ward SA; Bray PG; Davies J; Oh CH; Posner GH
Chembiochem; 2005 Nov; 6(11):2048-54. PubMed ID: 16222725
[TBL] [Abstract][Full Text] [Related]
7. Iron-mediated degradation kinetics of substituted dispiro-1,2,4-trioxolane antimalarials.
Creek DJ; Charman WN; Chiu FC; Prankerd RJ; McCullough KJ; Dong Y; Vennerstrom JL; Charman SA
J Pharm Sci; 2007 Nov; 96(11):2945-56. PubMed ID: 17549767
[TBL] [Abstract][Full Text] [Related]
8. Heme as trigger and target for trioxane-containing antimalarial drugs.
Meunier B; Robert A
Acc Chem Res; 2010 Nov; 43(11):1444-51. PubMed ID: 20804120
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, derivatization, and structure-activity relationships of simplified, tricyclic, 1,2,4-trioxane alcohol analogues of the antimalarial artemisinin.
Cumming JN; Wang D; Park SB; Shapiro TA; Posner GH
J Med Chem; 1998 Mar; 41(6):952-64. PubMed ID: 9526569
[TBL] [Abstract][Full Text] [Related]
10. Conversion of antimalarial drug artemisinin to a new series of tricyclic 1,2,4-trioxanes1.
Singh C; Chaudhary S; Kanchan R; Puri SK
Org Lett; 2007 Oct; 9(21):4327-9. PubMed ID: 17877363
[TBL] [Abstract][Full Text] [Related]
11. Alkylation of manganese(II) tetraphenylporphyrin by a synthetic antimalarial trioxane.
Berrien JF; Provot O; Mayrargue J; Coquillay M; Cicéron L; Gay F; Danis M; Robert A; Meunier B
Org Biomol Chem; 2003 Aug; 1(16):2859-64. PubMed ID: 12968336
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the reactivity of antimalarial 1,2,4,5-tetraoxanes with 1,2,4-trioxolanes in the presence of ferrous iron salts, heme, and ferrous iron salts/phosphatidylcholine.
Bousejra-El Garah F; Wong MH; Amewu RK; Muangnoicharoen S; Maggs JL; Stigliani JL; Park BK; Chadwick J; Ward SA; O'Neill PM
J Med Chem; 2011 Oct; 54(19):6443-55. PubMed ID: 21888440
[TBL] [Abstract][Full Text] [Related]
13. Drug delivery to the malaria parasite using an arterolane-like scaffold.
Fontaine SD; Spangler B; Gut J; Lauterwasser EM; Rosenthal PJ; Renslo AR
ChemMedChem; 2015 Jan; 10(1):47-51. PubMed ID: 25314098
[TBL] [Abstract][Full Text] [Related]
14. Kinetic parameters for the reaction of 1,2,4-trioxolanes and artemisinin with iron(II): New evidence for the source of antimalarial activity.
Lopes NS; Ciscato LFML
Chem Biol Drug Des; 2018 Jan; 91(1):328-331. PubMed ID: 28636765
[TBL] [Abstract][Full Text] [Related]
15. New efficient artemisinin derived agents against human leukemia cells, human cytomegalovirus and Plasmodium falciparum: 2nd generation 1,2,4-trioxane-ferrocene hybrids.
Reiter C; Fröhlich T; Zeino M; Marschall M; Bahsi H; Leidenberger M; Friedrich O; Kappes B; Hampel F; Efferth T; Tsogoeva SB
Eur J Med Chem; 2015 Jun; 97():164-72. PubMed ID: 25965779
[TBL] [Abstract][Full Text] [Related]
16. Spiroadamantyl 1,2,4-trioxolane, 1,2,4-trioxane, and 1,2,4-trioxepane pairs: relationship between peroxide bond iron(II) reactivity, heme alkylation efficiency, and antimalarial activity.
Wang X; Creek DJ; Schiaffo CE; Dong Y; Chollet J; Scheurer C; Wittlin S; Charman SA; Dussault PH; Wood JK; Vennerstrom JL
Bioorg Med Chem Lett; 2009 Aug; 19(16):4542-5. PubMed ID: 19616946
[TBL] [Abstract][Full Text] [Related]
17. Structure-Activity Relationships of the Antimalarial Agent Artemisinin 10. Synthesis and Antimalarial Activity of Enantiomers of
Jahan M; Leon F; Fronczek FR; Elokely KM; Rimoldi J; Khan SI; Avery MA
Molecules; 2021 Jul; 26(14):. PubMed ID: 34299438
[TBL] [Abstract][Full Text] [Related]
18. A Click Chemistry-Based Proteomic Approach Reveals that 1,2,4-Trioxolane and Artemisinin Antimalarials Share a Common Protein Alkylation Profile.
Ismail HM; Barton VE; Panchana M; Charoensutthivarakul S; Biagini GA; Ward SA; O'Neill PM
Angew Chem Int Ed Engl; 2016 May; 55(22):6401-5. PubMed ID: 27089538
[TBL] [Abstract][Full Text] [Related]
19. Antimalarial activities of (+)-deoxoartemisitene and its novel C-11, 13 derivatives.
Jung M; Lee K; Jung H; Kendrick H; Yardley V; Croft SL
Bioorg Med Chem Lett; 2004 Apr; 14(8):2001-3. PubMed ID: 15050646
[TBL] [Abstract][Full Text] [Related]
20. Spiro- and dispiro-1,2-dioxolanes: contribution of iron(II)-mediated one-electron vs two-electron reduction to the activity of antimalarial peroxides.
Wang X; Dong Y; Wittlin S; Creek D; Chollet J; Charman SA; Tomas JS; Scheurer C; Snyder C; Vennerstrom JL
J Med Chem; 2007 Nov; 50(23):5840-7. PubMed ID: 17949067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
